In LC, Nasser et al. showed that miR-1 expression is reduced in LC and inhibits the tumorigenic potential of LC cells by down-regulating oncogenic targets, such as MET and FoxP118. The gene discussed is MET; the disease is laryngotracheoesophageal cleft.